Info for shareholders
Content
Financial services [top]
Omega Pharma makes an appeal to the following organisations for providing financial services to its shareholders:
Here is an overview of the gross dividends per share that have been paid out (the net dividend is mentioned between brackets)
1997 EUR 0.0702 (EUR 0.0526)
1998 EUR 0.1983 (EUR 0.1487)
1999 EUR 0.0330 (EUR 0.0250) After split of the shares 10:1
2000 EUR 0.05 (EUR 0.0375)
2001 EUR 0.09 (EUR 0.06)
2002 EUR 0.12 (EUR 0.09)
2003 EUR 0.18 (EUR 0.135)
2004 EUR 0.24 (EUR 0.18)
2005 EUR 0.32 (EUR 0.24)
2006 EUR 0.40 (EUR 0.30)
2007 EUR 0.50 (EUR 0.375)
2008 EUR 0.60 (EUR 0.50)
2009 EUR 0.80 (EUR 0.60)
|
Situation July 2, 2010
|
| |
|---|---|---|
|
Effective voting rights (shares issued) |
24 231 080 |
|
|
Future voting rights (warrants) |
284 452 |
|
|
Total of effective and future voting rights |
24 515 532 |
|
The chart below has been developed on the basis of the effective voting rights (the "denominator") and takes account of the most recent declarations.
|
Situation on July 26, 2010 according to the received declarations | |
|---|---|
|
Couckinvest NV/Marc Coucke (declaration of September 22, 2008 and January 29, 2009)
|
30.01% |
|
Treasury shares (declaration of September 22, 2008)
|
3.86% |
|
Capital Research and Management Company (notification of situation June 14, 2010)
|
5.06% |
|
BlackRock (notification press release July 26, 2010)
|
3.05%
|
|
Public |
58.02% |
|
Total
|
100.00% |
Based on the above-mentioned base declarations, the entire free float (excluding Couckinvest/Marc Coucke and the treasury shares) thus amounts to 66,13%.
Article 11 of the articles of association of the company specifies that participations must be notified as soon as a threshold of 3%, 5%, 7.5% and any multiple of 5% has been passed.
General shareholders meeting [top]
The specifications regarding the general meeting of shareholders are included in the articles 30 until 39 included of the articles of association of the company.
The annual general shareholders meeting takes place at the official company address every first Monday of May, starting at 19.00 CET.
The convocation, the agenda and the proxy form for each general shareholders meeting are published in this web site under the heading Press releases.
The conditions for admission to the general meetings of shareholders are included in the Company's articles of associates and are also stated in the convocations to each General Meeting.
For specific questions concerning the participation at a general shareholders meeting, please contact Mrs Sabine Van Coppenolle (sabine.vancoppenolle@omega-pharma.be - tel. 0032 (9)381 03 20).
Codes
Listing
Key figures egarding the share in 2009 [top]
On July 2 2010, the share capital amounted to EUR 16 467 228.26 - represented by 24 231 080 shares.
Stock exchange data